ARROWHEAD PHARMACEUTICALS, INC. — Proxy Solicitation & Information Statement 2024

Jan 26, 2024

DEFA14A 1 defa14a-noticeofinternetav.htm DEFA14A Document created using Wdesk Copyright 2024 Workiva Document

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

(Amendment No.__)

Filed by the Registrant

Filed by a Party other than the Registrant

Check the appropriate box:

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material Pursuant to §240.14a-12

ARROWHEAD PHARMACEUTICALS, INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

No fee required.

Fee paid previously with preliminary materials

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.